Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. Brand New. Soft Cover International Edition. Different ISBN and Cover Image. Priced lower than the standard editions which is usually intended to make them more affordable for students abroad. The core content of the book is generally the same as the standard edition. The country selling restrictions may be printed on the book but is no problem for the self-use. This Item maybe shipped from US or any other country as we have multiple locations worldwide.
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 304,27
Anzahl: 10 verfügbar
In den WarenkorbHRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
EUR 325,10
Anzahl: Mehr als 20 verfügbar
In den WarenkorbGebunden. Zustand: New. Chi-Jen Lee, Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee, Mei-Ling ChenThe pharmaceutical industry is on the verge of an exciting and challenging century. Advances in pharmaceutical sciences have dramatically changed the processes of discovery a.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 385,91
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 1st edition. 500 pages. 10.25x7.00x1.25 inches. In Stock.
Sprache: Englisch
Verlag: Taylor & Francis Inc Sep 2005, 2005
ISBN 10: 0849321859 ISBN 13: 9780849321856
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Neuware - Based on the bestselling Handbook of Phase I/II Clinical Drug Trials, this newly named, completely revised and expanded volume details how recent advances and increasing demands for safety and efficacy have changed the process by which drugs are developed and approved. It examines critical considerations for trials conducted during each phase of clinical development. It also explores early pre-clinical evaluations of pharmacological activity and safety. Ten sections examining clinical assessment are organized according to anatomical targets (e.g. CNS, liver), functions (e.g. metabolic, chemotherapeutic) with another section covering vaccines, biotechnology-derived therapeutics, and plant-based medicines.